Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01541826 · ClinicalTrials.gov registry record · NA
Study of Chokeberry to Reduce Cardiovascular Disease Risk in Former Smokers
A NA study, sponsored by University of Connecticut.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT01541826: Completed NA study, sponsored by University of Connecticut.
NCT01541826 is a NA study that has completed, run by University of Connecticut. The registered enrollment target is 62 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01541826, a NA study, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
The purpose of this project is to determine whether chokeberry polyphenols mitigate cardiovascular disease risk in former smokers.
Primary Outcome
Change in LDL cholesterol from baseline after chronic supplementation. Not determined in Chokeberry Extract Capsule (Acute) arm as this arm was a one-time dose.
Interventions
- DIETARY_SUPPLEMENT Placebo capsule
- DIETARY_SUPPLEMENT Chokeberry Extract
- DIETARY_SUPPLEMENT Chokeberry extract capsule, acute
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2012-02 |
| Est. Completion | 2016-12 |
| Phase | NA |
What the finished NCT01541826 record still lists
NCT01541826 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo capsule is the first listed.
NCT01541826 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01541826 about?
NCT01541826 is a clinical study titled "Study of Chokeberry to Reduce Cardiovascular Disease Risk in Former Smokers". The purpose of this project is to determine whether chokeberry polyphenols mitigate cardiovascular disease risk in former smokers.
What is the current status of trial NCT01541826?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2012-02. Estimated completion is 2016-12.
What interventions are being tested in trial NCT01541826?
The interventions under investigation include: Placebo capsule (DIETARY_SUPPLEMENT), Chokeberry Extract (DIETARY_SUPPLEMENT), Chokeberry extract capsule, acute (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01541826?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01541826's enrollment target sits among peer trials
62 1157th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia